Zhiling Yu
Associate Professor
 Pharmacology
Research Centre for Standardization of Chinese Medicines
Hong Kong
Biography
Present Assistant Professor, School of Chinese Medicine, Hong Kong Baptist University, before that he is a Professor, School of Life Sciences, Xiamen University, China. From 20003-2004 he is a Research Associate, Hong Kong University of Science and Technology. He done his Ph. D. in 2003 from Hong Kong University of Science and Technology, Hong Kong
Research Interest
Investigation of hepatic lipid lowering agents. Establishment of in vitro human hepatosteatosis model. Identification of molecular targets of anticancer agents in liver cancer cells.
Publications
-
HY Kwan, X Chao, T Su, XQ Fu, B Liu, AK Tse, WF Fong, ZL Yu*. Dietary lipids and adipocytes: potential therapeutic targets in cancers. The Journal of Nutritional Biochemistry. 2015, 26(4): 303-311 Y Ye, XJ Chao, JF Wu, BC Cheng, T Su, XQ Fu, T Li, H Guo, AK Tse, HY Kwan, J Du, GX Chou, ZL Yu*. ERK/GSK3β signaling is involved in atractylenolide I-induced apoptosis and cell cycle arrest in melanoma cells. Oncology Reports. 2015 Jul 6. doi: 10.3892/or.2015.4111. T Su, H Yu, HY Kwan, XQ Ma, HH Cao, CY Cheng, AK Leung, CL Chan, WD Li, H Cao, WF Fong, ZL Yu*. Comparisons of the chemical profiles, cytotoxicities and anti-inflammatory effects of raw and rice wine-processed Herba Siegesbeckiae. Journal of Ethnopharmacology. 2014, 156: 365-369
